Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
2.
Rev Stomatol Chir Maxillofac ; 106(3): 177-80, 2005 Jun.
Article in French | MEDLINE | ID: mdl-15976707

ABSTRACT

INTRODUCTION: Ameloblastoma is a benign odontogenic tumor which can be locally aggressive and invasive. Metastases are rare but possible and must be considered as a malignant form of the tumor. OBSERVATION: A 50-year-old woman presented a jugal metastasis of a mandibular ameloblastom which had been treated several times 28 years earlier. Six months after resection of the metastasis, the patient developed multiple cervical node metastases which were removed by radical curettage. Five months later, new metastases developed on the scalp and three months later a voluminous metastasis involving the right hemiface extended to the base of the skull. Surgical resection was only partial followed by radiotherapy. Ten months later the outcome was favorable. DISCUSSION: The absence of any histological sign of malignity in the primary tumor and in the metastases, as observed in our patient, is remarkable. Metastases generally develop in the lung (61-80% of cases). Metastases to the scalp have never been described. The time to development of a metastasis is generally very long and metastases usually remain asymptomatic. Progression is very slow, like for the primary tumor. Several factors predictive of metastasis have been described: female gender, age at onset of primary tumor (2nd to 3rd decade) and multiple local recurrences. There is no standard treatment for metastases. Chemotherapy is not effective. Radiotherapy may be effective, particularly when lesions are not accessible to surgery. Surgical resection remains the treatment of choice.


Subject(s)
Ameloblastoma/secondary , Mandibular Neoplasms/pathology , Ameloblastoma/pathology , Female , Follow-Up Studies , Head and Neck Neoplasms/secondary , Humans , Lymphatic Metastasis/pathology , Middle Aged , Paranasal Sinus Neoplasms/secondary , Scalp/pathology , Skin Neoplasms/secondary , Skull Neoplasms/secondary , Zygoma/pathology
3.
Br J Ophthalmol ; 85(12): 1406-10, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11734509

ABSTRACT

BACKGROUND: Evidence of widespread distribution of trachoma in Egypt had not been clarified as previous surveys were limited to individual communities which may not have been representative of the general population. The Nile Delta of Egypt presents a unique environment for trachoma to persist. Economic improvements in the past decade have affected even the poorest rural environments; availability of electricity is now found in many rural communities. Availability of water in Nile Delta has always been good but poor hygienic conditions have been the primary factor in trachoma transmission. A survey of trachoma was undertaken in Menofiya governorate to determine if Egypt should be identified as trachoma endemic and targeted for trachoma control efforts. METHODS: A multistage random cluster study design was used with the target population defined as adults aged 50 and over and children aged 2-6 years from throughout the governorate. Among preschool children only trachoma was graded while among adults presenting visual acuity and cause of vision loss or blindness were also recorded. Adults were interviewed regarding past trichiasis surgery; those currently with trichiasis or a history of trichiasis surgery were also interviewed regarding outcome of surgery. RESULTS: A total of 3272 children aged 2-6 and 3322 adults age 50+ were enumerated. Among the children 81.3% were examined and among the adults 73.0% were examined. Active trachoma (follicles (TF) and/or intense inflammation (TI)) was found among 36.5% (95% confidence interval (CI) 34.7-38.3%) of the children. TI was 1.89 (95% CI 1.22-2.94) times more common in rural children compared to urban children. The prevalence of trichiasis (TT) in adults was 6.5%; women had an age adjusted odds of trichiasis of 1.68 (95% CI 1.18-2.39) compared to men. Trichiasis was 2.11 times (95% CI 1.33-3.37) more common in rural Menofiya compared to urban Menofiya. TT accounts for blindness (presenting vision <3/60) in 8% of patients and accounts for 13.2% of visual impairment. Overall, trichiasis surgical coverage was 34.4%, slightly higher among men than women. The outcome of trichiasis surgery was poor in 44.4% of cases. CONCLUSION: Trachoma is a serious public health problem in Menofiya governorate and a significant contributor to vision loss. These findings would suggest that continued poor hygienic conditions in rural Egypt have limited the reduction of active trachoma even in the face of significant improvements in socioeconomic status. Furthermore, the high proportion of trichiasis surgery cases with a poor outcome would indicate a need to reassess current surgical practices in Egypt and improve training and monitoring.


Subject(s)
Developing Countries/statistics & numerical data , Trachoma/epidemiology , Aged , Blindness/epidemiology , Blindness/microbiology , Child , Child, Preschool , Cicatrix/microbiology , Cluster Analysis , Conjunctival Diseases/microbiology , Egypt/epidemiology , Environment , Eyelid Diseases/microbiology , Eyelid Diseases/surgery , Health Services Accessibility , Health Surveys , Humans , Middle Aged , Prevalence , Risk Factors , Trachoma/complications
4.
J Org Chem ; 66(11): 4055-7, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11375036
5.
Trop Med Int Health ; 3(9): 721-7, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9754667

ABSTRACT

We performed a series of ELISAs to evaluate the diagnostic significance of two Schistosoma mansoni proteins, Sm31 (cysteine proteinase, cathepsin B) and Sm32 (asparaginyl endopeptidase). Our study populations were chosen from two villages in an endemic area close to Alexandria. Using fusion proteins MS2-Sm31 and MS2-Sm32 as antigens, 70% and 78.9%, respectively, of patient sera from 134 parasitologically confirmed cases reacted positively. The percentage of seropositivity increased to 84.5% when parasite-derived proteins Sm31 and Sm32 were used. The serum levels of antibodies to these two proteins in recombinant or native forms do not correlate with intensity of infection and hence are detected even when egg counts are low, which makes proteins Sm31 and Sm32 useful antigens in the identification of S. mansoni infected cases, particularly in endemic areas in Egypt.


Subject(s)
Antibodies, Helminth/blood , Antigens, Helminth/immunology , Cysteine Endopeptidases/immunology , Endemic Diseases , Helminth Proteins/immunology , Plant Proteins , Schistosoma mansoni/immunology , Schistosomiasis mansoni/diagnosis , Schistosomiasis mansoni/immunology , Adolescent , Adult , Animals , Case-Control Studies , Child , Child, Preschool , Egypt/epidemiology , Enzyme-Linked Immunosorbent Assay , Feces/parasitology , Female , Humans , Male , Middle Aged , Parasite Egg Count , Reproducibility of Results , Schistosomiasis mansoni/epidemiology , Sensitivity and Specificity , Seroepidemiologic Studies , Severity of Illness Index
6.
J Am Acad Dermatol ; 37(5 Pt 1): 740-5, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9366820

ABSTRACT

BACKGROUND: Onychomycosis is an increasing problem with limited therapeutic options. OBJECTIVE: We evaluated the safety and efficacy, of oral terbinafine, a new fungicidal antimycotic, in patients with toenail onychomycosis. METHODS: A North American multicenter, double-blind, placebo-controlled study evaluated the mycologic and clinical efficacy of oral terbinafine 250 mg/day for 12 or 24 weeks in 358 patients with toenail onychomycosis. RESULTS: A total of 74% of patients treated with 12 or 24 weeks of terbinafine achieved a successful clinical outcome. Approximately 11% of terbinafine responders showed evidence of relapse 18 of 21 months after cessation of treatment. Terbinafine was well tolerated; most adverse events were transient and mild to moderate in severity. CONCLUSION: The results of this study confirm that oral terbinafine is a safe and effective therapy for the treatment of onychomycosis.


Subject(s)
Antifungal Agents/therapeutic use , Naphthalenes/therapeutic use , Onychomycosis/drug therapy , Abdominal Pain/chemically induced , Administration, Oral , Adult , Aged , Antifungal Agents/adverse effects , Diarrhea/chemically induced , Double-Blind Method , Drug Eruptions/etiology , Epidermophyton/isolation & purification , Female , Follow-Up Studies , Humans , Male , Middle Aged , Naphthalenes/adverse effects , Onychomycosis/diagnosis , Onychomycosis/microbiology , Recurrence , Terbinafine , Toes , Trichophyton/isolation & purification
9.
Arch Dermatol ; 125(12): 1685-8, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2556081

ABSTRACT

Acute graft-vs-host disease occurring during the early weeks of life has been previously reported as a rare disease entity. We report a case of acute graft-vs-host disease in a female infant with an immunodeficiency that was thought to be secondary to intrauterine or neonatal cytomegalovirus infection or, less likely, to a severe combined immunodeficiency. The patient presented with a triad of failure to thrive, diarrhea, and maculopapular and petechial rash. The first clue to diagnosis was the skin biopsy finding of an epidermal lymphocytic infiltrate in association with individual necrotic keratinocytes. The diagnosis was confirmed at autopsy. In the absence of an obvious graft, the disease is believed to have been the result of maternofetal T-cell transfer in utero or at delivery.


Subject(s)
Cytomegalovirus Infections/complications , Graft vs Host Disease , Immunologic Deficiency Syndromes/complications , Female , Graft vs Host Disease/complications , Graft vs Host Disease/etiology , Graft vs Host Disease/pathology , Humans , Immunologic Deficiency Syndromes/etiology , Infant
SELECTION OF CITATIONS
SEARCH DETAIL
...